These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 24313118)

  • 1. Viral load monitoring: shifting paradigms in clinical practice.
    Baum P; Heilek G
    MLO Med Lab Obs; 2013 Nov; 45(11):8, 10, 12 passim. PubMed ID: 24313118
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiretroviral treatment with nucleoside analogs does not decrease the viremia of the hepatitis C virus in patients with HIV-1 infection].
    Macías J; Sánchez-Quijano A; Rey C; Lissen E
    Med Clin (Barc); 1998 Jun; 111(3):118-9. PubMed ID: 9706609
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful testing protocols in virology.
    Kelley VA; Caliendo AM
    Clin Chem; 2001 Aug; 47(8):1559-62. PubMed ID: 11468267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distinct contributions of fitness and genetic barrier to the development of antiviral drug resistance.
    Götte M
    Curr Opin Virol; 2012 Oct; 2(5):644-50. PubMed ID: 22964133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection.
    Chary A; Winters MA; Eisen R; Knight TH; Asmuth DM; Holodniy M
    J Med Virol; 2012 Mar; 84(3):431-7. PubMed ID: 22246828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summary of the international consensus symposium on management of HIV, CMV and hepatitis virus infections.
    de Jong MD; Boucher CA; Danner SA; Gazzard B; Griffiths PD; Katlama C; Lange JM; Richman DD; Vella S
    Antiviral Res; 1998 Jan; 37(1):1-16. PubMed ID: 9497068
    [No Abstract]   [Full Text] [Related]  

  • 7. Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact.
    Baldanti F; Gerna G
    J Antimicrob Chemother; 2003 Sep; 52(3):324-30. PubMed ID: 12888590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life.
    Cacoub P; Rosenthal E; Halfon P; Sene D; Perronne C; Pol S
    J Viral Hepat; 2006 Oct; 13(10):678-82. PubMed ID: 16970599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in European HIV-infected patients with anti-HCV antibodies.
    Pascual Pareja JF; Montes ML; González-García J; Arribas JR
    J Infect Dis; 2009 May; 199(10):1556-7; author reply 1557. PubMed ID: 19392631
    [No Abstract]   [Full Text] [Related]  

  • 10. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribavirin: is it a mutagen for hepatitis C virus?
    Perelson AS; Layden TJ
    Gastroenterology; 2007 May; 132(5):2050-2. PubMed ID: 17484896
    [No Abstract]   [Full Text] [Related]  

  • 12. Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV co-infected patients.
    Bader T
    J Viral Hepat; 2010 Mar; 17(3):227. PubMed ID: 19758277
    [No Abstract]   [Full Text] [Related]  

  • 13. Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection.
    Fialaire P; Payan C; Vitour D; Chennebault JM; Loison J; Pichard E; Lunel F
    J Infect Dis; 1999 Aug; 180(2):574-5. PubMed ID: 10395889
    [No Abstract]   [Full Text] [Related]  

  • 14. Entecavir can select for M184V of HIV-1: a case of an HIV/hepatitis B (HBV) naïve patient treated for chronic HBV.
    Jain MK; Zoellner CL
    AIDS; 2007 Nov; 21(17):2365-6. PubMed ID: 18090296
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease.
    Humar A; Kumar D; Gilbert C; Boivin G
    J Infect Dis; 2003 Aug; 188(4):581-4. PubMed ID: 12898447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel difluoro-cyclopropyl guanine nucleosides and their phosphonate analogues as potent antiviral agents.
    Li H; Yoo JC; Kim E; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2011 Nov; 30(11):945-60. PubMed ID: 22060557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV and hepatitis C coinfection.
    Matthews GV; Rockstroh J
    Curr Opin HIV AIDS; 2011 Nov; 6(6):449-50. PubMed ID: 22001889
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the Abbott Realtime HIV-1 and HCV viral load assays with commercial competitor assays.
    Schutten M
    Expert Rev Mol Diagn; 2008 Jul; 8(4):369-77. PubMed ID: 18598219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of HIV infection, highly active antiretroviral therapy, and hepatitis C coinfection on serum interleukin-27.
    Guzzo C; Hopman WM; Che Mat NF; Wobeser W; Gee K
    AIDS; 2010 Jun; 24(9):1371-4. PubMed ID: 20375875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid substitutions in the nonstructural region 5A of hepatitis C virus genotypes 2a and 2b and its relation to viral load and response to interferon.
    Kobayashi M; Watanabe K; Ishigami M; Murase K; Ito H; Ukai K; Yano M; Takagi K; Hattori M; Kakumu S; Yoshioka K
    Am J Gastroenterol; 2002 Apr; 97(4):988-98. PubMed ID: 12003437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.